Skip to main content
. Author manuscript; available in PMC: 2017 Jul 12.
Published in final edited form as: J Perinatol. 2017 Jan 12;37(4):340–344. doi: 10.1038/jp.2016.247

Table 3.

Adjusted Odds of Adverse Outcomes Compared to Single Agent, BP<140/90 mm Hg

Multiple Agent
<140/90
Single Agent ≥140/90 Multiple Agent
≥140/90
Superimposed
Preeclampsia*
1.35 (0.75-2.46) 2.04 (1.15-3.63) 2.27 (1.19-4.28)
Superimposed
Severe PE*
1.34 (0.64-2.81) 1.33 (0.63-2.83) 2.86 (1.41-5.77)
Cesarean Delivery 0.89 (0.51-1.53) 1.04 (0.60-1.81) 1.25 (0.64-2.45)
Admissions to r/o PE 3.18 (1.56-6.51) 2.44 (1.12-5.31) 3.21 (1.36-7.58)
SGA§ 1.36 (0.65-2.86) 1.40 (0.68-2.88) 1.82 (0.81-4.07)
PTB <35 weeks 1.35 (0.73-2.46) 1.97 (1.09-3.56) 3.05 (1.59-5.83)
Composite Neonatal ** 1.63 (0.82-3.25) 1.72 (0.86-3.45) 3.84 (1.96-7.50)
*

Adjusted for history of preeclampsia, nulliparity

Adjusted for prior vaginal delivery, diabetes, tobacco use

Adjusted for diabetes

§

Adjusted for race, body mass index, diabetes, and tobacco use

Adjusted for prior preterm delivery, nulliparity

**

Adjusted for nulliparity